The lentivirus human immunodeficiency virus (HIV) causes AIDS by interacting with a large
number of different cells in the body and escaping the host immune response against it. HIV …

An effective vaccine usually requires more than one time immunization in the form of prime–
boost. Traditionally the same vaccines are given multiple times as homologous boosts. New …

Interaction with the CD4 receptor enhances the exposure on the human immunodeficiency
type 1 gp120 exterior envelope glycoprotein of conserved, conformation-dependent …

This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

Vaccine protection against the human immunodeficiency virus (HIV) and the related simian
immunodeficiency virus (SIV) in animal models is proving to be a difficult task. The difficulty …

RNA polymerase II transcripts, heterogeneous nuclear RNAs (hnRNAs), associate in the
nucleus with specific proteins that bind premessenger RNA (hnRNP proteins) 1, 2 and with …

Various safe and effective COVID-19 vaccines utilizing different platforms (mRNA,
adenovirus vector, inactivated virus-based) are available against SARS-CoV-2 infection. A …

Virus–specific antibodies protect individuals against a wide variety of viral infections 1–7. To
assess whether human immunodeficiency virus type 1 (HIV–1) envelope–specific antibodies …

The rate of progression of HIV disease may be substantially different among HIV-infected
individuals. Following infection of the host with any virus, the delicate balance between virus …

Six recombinant human Fab fragments that were derived from the same human
immunodeficiency virus type 1 (HIV-1)-infected individual and are directed against the CD4 …